Structure Therapeutics GPCR
NASDAQ GPCR
$47.34 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026)

Structure Therapeutics (GPCR) posted quarterly Prepaid Assets of $32.1 million for Q1 2026, up 151.92% year-over-year from $12.7 million in Q1 2025, and up 33.14% quarter-over-quarter from $24.1 million in Q4 2025.

Analysis

Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026) Analysis & Trends

Structure Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $32.1 million for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 151.92% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at $32.1 million (up 151.92% YoY), while the FY2025 annual figure was $24.1 million, up 213.35% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $32.1 million, up from $24.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $32.1 million in Q1 2026, with the low at $2.2 million in Q4 2022.
  • The 5-year median for Prepaid Assets is $9.4 million (2024), against an average of $11.3 million.
  • Peak annual rise in Prepaid Assets reached 213.35% in 2025, while the deepest fall reached 1.32% in 2025.
  • Structure Therapeutics' Prepaid Assets stood at $2.2 million in 2022, then surged by 179.58% to $6.3 million in 2023, then grew by 22.4% to $7.7 million in 2024, then surged by 213.35% to $24.1 million in 2025, then soared by 33.14% to $32.1 million in 2026.
  • Business Quant data shows GPCR's Prepaid Assets at $32.1 million in Q1 2026, $24.1 million in Q4 2025, and $15.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Structure Therapeutics 10.32 Bn 10.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.37 Mn
Mar 31, 2026 32.09 Mn
Dec 31, 2025 24.11 Mn
Sep 30, 2025 14.98 Mn
Jun 30, 2025 12.80 Mn
Mar 31, 2025 12.74 Mn
Dec 31, 2024 7.69 Mn
Sep 30, 2024 8.37 Mn
Jun 30, 2024 10.50 Mn
Mar 31, 2024 12.91 Mn
Dec 31, 2023 6.29 Mn
Sep 30, 2023 4.54 Mn
Jun 30, 2023 3.64 Mn
Mar 31, 2023 5.29 Mn
Dec 31, 2022 2.25 Mn